• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓性微血管病:多学科团队方法。

Thrombotic Microangiopathy: A Multidisciplinary Team Approach.

机构信息

Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA.

Hematology-Oncology Section, Department of Medicine, Boston University School of Medicine, Boston, MA.

出版信息

Am J Kidney Dis. 2017 Nov;70(5):715-721. doi: 10.1053/j.ajkd.2017.05.017. Epub 2017 Jul 15.

DOI:10.1053/j.ajkd.2017.05.017
PMID:28720207
Abstract

Thrombotic microangiopathy (TMA) is characterized by the presence of microangiopathic hemolytic anemia and thrombocytopenia along with organ dysfunction, and pathologically, by the presence of microthrombi in multiple microvascular beds. Delays in diagnosis and initiation of therapy are common due to the low incidence, variable presentation, and poor awareness of these diseases, underscoring the need for interdisciplinary approaches to clinical care for TMA. We describe a new approach to improve clinical management via a TMA team that originally stemmed from an Affinity Research Collaborative team focused on thrombosis and hemostasis. The TMA team consists of clinical faculty from different disciplines who together are charged with the responsibility to quickly analyze clinical presentations, guide laboratory testing, and streamline prompt institution of treatment. The TMA team also includes faculty members from a broad range of disciplines collaborating to elucidate the pathogenesis of TMA. To this end, a clinical database and biorepository have been constructed. TMA leaders educate front-line providers from other departments through presentations in various forums across multiple specialties. Facilitated by an Affinity Research Collaborative mechanism, we describe an interdisciplinary team dedicated to improving both clinical care and translational research in TMA.

摘要

血栓性微血管病(TMA)的特征是存在微血管病性溶血性贫血和血小板减少症以及器官功能障碍,病理上存在多个微脉管中的微血栓。由于这些疾病的发病率低、表现多样且认知度低,导致诊断和治疗的延误很常见,这突显了需要采用跨学科方法来进行 TMA 的临床护理。我们描述了一种通过 TMA 团队改善临床管理的新方法,该团队最初源自一个专注于血栓形成和止血的亲和力研究协作团队。TMA 团队由来自不同学科的临床教师组成,共同负责快速分析临床表现、指导实验室检测,并简化及时开始治疗的流程。TMA 团队还包括来自广泛学科的教师成员,共同阐明 TMA 的发病机制。为此,已经构建了一个临床数据库和生物库。TMA 负责人通过在多个专业的各种论坛上进行演讲,向其他部门的一线医护人员进行教育。在亲和力研究协作机制的推动下,我们描述了一个致力于改善 TMA 的临床护理和转化研究的跨学科团队。

相似文献

1
Thrombotic Microangiopathy: A Multidisciplinary Team Approach.血栓性微血管病:多学科团队方法。
Am J Kidney Dis. 2017 Nov;70(5):715-721. doi: 10.1053/j.ajkd.2017.05.017. Epub 2017 Jul 15.
2
Thrombotic microangiopathy and indications for therapeutic plasma exchange.血栓性微血管病及治疗性血浆置换的适应证
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):444-9. doi: 10.1182/asheducation-2014.1.444. Epub 2014 Nov 18.
3
Renal Thrombotic Microangiopathy: A Review.肾血栓性微血管病:综述。
Am J Kidney Dis. 2023 May;81(5):591-605. doi: 10.1053/j.ajkd.2022.10.014. Epub 2022 Dec 10.
4
Thrombotic microangiopathy and pregnancy.血栓性微血管病与妊娠
Ceska Gynekol. 2020 Winter;85(1):18-28.
5
Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.澳大利亚和新西兰关于血栓性微血管病诊断与管理的共识意见。
Nephrology (Carlton). 2018 Jun;23(6):507-517. doi: 10.1111/nep.13234.
6
Thrombotic microangiopathies of pregnancy: Differential diagnosis.妊娠期血栓性微血管病:鉴别诊断。
Pregnancy Hypertens. 2018 Apr;12:29-34. doi: 10.1016/j.preghy.2018.02.007. Epub 2018 Feb 16.
7
Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.奎宁诱导的血栓性微血管病:19 例患者报告。
Am J Kidney Dis. 2017 Nov;70(5):686-695. doi: 10.1053/j.ajkd.2017.05.023. Epub 2017 Aug 3.
8
Thrombotic Microangiopathy Syndrome in a Basic Underwater Demolition/SEAL Student.一名基础水下爆破/海豹突击队学员的血栓性微血管病综合征
J Spec Oper Med. 2016 fall;16(3):16-19. doi: 10.55460/GUJX-4F6D.
9
Thrombotic Microangiopathy Syndromes-Common Ground and Distinct Frontiers.血栓性微血管病综合征——共同基础与独特前沿。
Adv Chronic Kidney Dis. 2022 Mar;29(2):149-160.e1. doi: 10.1053/j.ackd.2021.11.006.
10
Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).血栓性微血管病(TMAs)诊断与治疗的病理会诊
Am J Clin Pathol. 2016 Feb;145(2):158-65. doi: 10.1093/ajcp/aqv086.

引用本文的文献

1
The TMA team and TTP pathway improved outcomes in a cohort with Thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜研究团队及TTP通路改善了一组血栓性血小板减少性紫癜患者的治疗结果。
PLoS One. 2025 Jun 6;20(6):e0325417. doi: 10.1371/journal.pone.0325417. eCollection 2025.
2
Eculizumab Use in Scleroderma Renal Crisis With Thrombotic Microangiopathy: A Case Report.依库珠单抗用于治疗伴有血栓性微血管病的硬皮病肾危象:一例报告
Kidney Med. 2023 Nov 27;6(1):100753. doi: 10.1016/j.xkme.2023.100753. eCollection 2024 Jan.
3
Voice of a caregiver: call for action for multidisciplinary teams in the care for children with atypical hemolytic uremic syndrome.
一位照顾者的心声:呼吁为非典型溶血尿毒综合征患儿的护理组建多学科团队采取行动。
Pediatr Nephrol. 2024 Jul;39(7):1961-1963. doi: 10.1007/s00467-023-06158-8. Epub 2023 Oct 2.
4
Postsurgical Thrombotic Microangiopathy and Deregulated Complement.术后血栓性微血管病与补体失调
J Clin Med. 2022 Apr 29;11(9):2501. doi: 10.3390/jcm11092501.
5
What is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study.基于临床表现,原发性和继发性血栓性微血管病中血压对神经系统症状的影响和发生 ESKD 的风险:一项回顾性研究。
BMC Nephrol. 2022 Jan 20;23(1):39. doi: 10.1186/s12882-022-02672-3.
6
Evidences of histologic thrombotic microangiopathy and the impact in renal outcomes of patients with IgA nephropathy.IgA 肾病患者的组织学血栓性微血管病证据及其对肾脏结局的影响。
PLoS One. 2020 Nov 4;15(11):e0233199. doi: 10.1371/journal.pone.0233199. eCollection 2020.
7
Use of Eculizumab in Transplant-Associated Thrombotic Microangiopathy in a Patient With Polycystic Kidney Disease Immediately Post-Kidney Transplant: A Case Report.依库珠单抗在多囊肾病患者肾移植术后即刻发生的移植相关血栓性微血管病中的应用:一例报告
Kidney Med. 2020 Aug 5;2(5):652-656. doi: 10.1016/j.xkme.2020.06.007. eCollection 2020 Sep-Oct.
8
Monoclonal IgG4/2κ Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney Transplantation.依库珠单抗治疗肾移植复发性非典型溶血尿毒症综合征后的单克隆IgG4/2κ沉积
Kidney Med. 2019 May 9;1(3):139-143. doi: 10.1016/j.xkme.2019.03.005. eCollection 2019 May-Jun.
9
Optimal management of atypical hemolytic uremic disease: challenges and solutions.非典型溶血尿毒症综合征的优化管理:挑战与解决方案
Int J Nephrol Renovasc Dis. 2019 Sep 4;12:183-204. doi: 10.2147/IJNRD.S215370. eCollection 2019.
10
Etiology and Outcomes of Thrombotic Microangiopathies.血栓性微血管病的病因和结局。
Clin J Am Soc Nephrol. 2019 Apr 5;14(4):557-566. doi: 10.2215/CJN.11470918. Epub 2019 Mar 12.